A peer-reviewed study in which researchers concluded that ivermectin treatment during early COVID-19 “did not prevent” severe disease in high-risk patients has been criticized by an alliance of doctors for being “misleading.”
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
In the open-label randomized clinical trial, also referred to as the “The I-TECH Randomized Clinical Trial,” published in the JAMA Internal Medicine journal on Feb. 18, researchers said their findings “do not support the use of ivermectin for patients with COVID-19.”
“The study involved results from 490 patients with mild to moderate COVID-19 in Malaysia. Participants were aged 50 and over, with at least one documented comorbidity. People who did not develop symptoms or who had severe COVID-19 were not included in the trial,” The Epoch Times reported.
“The trial was conducted in 20 hospitals and a COVID-19 quarantine center in the country between May 31 and Oct. 25, 2021. Of the group, 249 participants received standard care, while 241 received a course of oral ivermectin over five days in addition to standard care.
Researchers said they found that 21.6 % of patients in the ivermectin group and 17.3 % in the standard care group progressed to “severe disease.”
There has already been a lot pf [previous discussions and inconsistent opinions on the matter.
“The World Health Organization features ivermectin on its List of Essential Medicines. It is also approved as an antiparasitic agent by the U.S. Food and Drug Administration (FDA).
However, the FDA has not approved the drug to treat or prevent COVID-19 in humans. According to the FDA, side effects of ivermectin include skin rash, nausea, and vomiting.
The American Medical Association, the American Pharmacists Association, and the American Society of Health-System Pharmacists said in a joint statement in September 2021 they were against its use to treat COVID-19 outside of a clinical trial.”
and to this day, there still are.
Nut, it’s loud and clear that they’re politically orchestrated and with a single political (business and profit) purpose.
Dr Pierre Kory, FLCCC president and chief medical officer, said the study’s conclusion is “flat out wrong and highly misleading.”
“In the study’s control group, two-and-a-half times more patients had to be placed on mechanical ventilation—and there were three times more deaths in the control group,” Kory, a pulmonologist, said in a statement. “This shows that ivermectin causes a 75 % risk reduction in death and further strengthens metadata of ivermectin’s large mortality benefits in severe COVID.”